PUBLICATION/ISSUE REVIEW COMPLETE
on 13 Nov 2024
Last Applicant/ Owned by
GSK Medicines Research Centre
Stevenage
GB
SG12NY
Serial Number
98380307 filed on 29th Jan 2024
Registration Number
N/A
Correspondent Address
Elizabeth K. Rucki
Filing Basis
1. intent to use
Disclaimer
NO DATA
XEVROS
Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related disea Read More
Classification Information
Class [005]
Pharmaceutical Products
Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98380307
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 84276539
44D Filed
No
44D Current
No
44E filed
Yes
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 07th Nov 2024 | ASSIGNED TO LIE |
| 07th Nov 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 07th Nov 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 07th Nov 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 16th Aug 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 14th Aug 2024 | NON-FINAL ACTION E-MAILED |
| 14th Aug 2024 | NON-FINAL ACTION WRITTEN |
| 14th Aug 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 14th Aug 2024 | ASSIGNED TO EXAMINER |
| 28th May 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |